Persistence with inhaled corticosteroid therapy in daily practice

Respiratory Medicine

Volumn 98, Issue 8, 2004, Pages 752-759

  Breekveldt Postma, N S ^a   Gerrits, C M J M ^b   Lammers, J W J ^c   Raaijmakers, J A M ^b,d   Herings, R M C ^a,d  

^a PHARMO INSTITUTE FOR DRUG OUTCOMES RESEARCH   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d GLAXOSMITHKLINE   (Netherlands)

Author keywords

Asthma; COPD; Discontinuation; Inhaled corticosteroid; Persistence; Prescription database

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTITUSSIVE AGENT; BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUTICASONE; MUCOLYTIC AGENT; XANTHINE DERIVATIVE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG INDICATION; DRUG USE; FEMALE; GROUPS BY AGE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICAL SPECIALIST; NETHERLANDS; PATIENT ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 3042593374     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2004.01.014     Document Type: Article

References (34)

1. Jeffery P.K. Structural and inflammatory changes in COPD: a comparison with asthma Thorax 53 2 1998 129-136
2. Anonymous. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med 1995;152(5 pt 2):S77-121.
3. GINA, Global Strategy for Asthma Management and Prevention. National Heart, Lung and Blood Institute, 2002.
4. Eisner M.D. Lieu T.A. Chi F. et al. Beta agonists, inhaled steroids, and the risk of intensive care unit admission for asthma Eur Respir J 17 2 2001 233-240
5. van den Boom G. Rutten-van Molken M.P. Molema J. Tirimanna P.R. van Weel C. van Schayck C.P. The cost effectiveness of early treatment with fluticasone propionate 250 microg twice a day in subjects with obstructive airway disease. Results of the DIMCA Program Am. J Respir Crit Care Med 164 11 2001 2057-2066
6. Calverley P.M. Inhaled corticosteroids are beneficial in chronic obstructive pulmonary disease Am J Respir Crit Care Med 161 2000 341-342
7. Barnes P.J. Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease Am J Respir Crit Care Med 161 2000 342-344
8. van der Valk P. Monninkhof E. van der Palen J. Zielhuis G. van Herwaarden C. Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the cope study Am J Respir Crit Care Med 166 2002 1358-1363
9. Sin D.D. Tu J.V. Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 164 2001 580-584
10. Caro J.J. Speckman J.L. Salas M. Raggio G. Jackson J.D. Persistence with treatment for hypertension in actual practice CMAJ 160 1 1999 31-37
11. Catalan V.S. LeLorier J. Predictors of long-term persistence on statins in a subsidized clinical population Value in Health 3 6 2000 417-426
12. Catalan V.S. Couture J.A. LeLorier J. Predictors of persistence of use of the novel antidiabetic agent acarbose Arch Intern Med 161 8 2001 1106-1112
13. Pilon D. Castilloux A.M. LeLorier J. Estrogen replacement therapy: determinants of persistence with treatment Obstet Gynecol 97 1 2001 97-100
14. Monane M. Bohn R.L. Gurwitz J.H. Glynn R.J. Levin R. Avorn J. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly Am J Hypertens 10 7 Pt 1 1997 697-704
15. Bloom B.S. Continuation of initial antihypertensive medication after 1 year of therapy Clin Ther 20 4 1998 671-681
16. Herings RMC. PHARMO: A record linkage system for postmarketing surveillance of prescription drugs in The Netherlands. Pharmaco-epidemiology and - therapy, Utrecht University, Utrecht 1993:232.
17. Herings R.M. Urquhart J. Leufkens H.G. Venous thromboembolism among new users of different oral contraceptives Lancet 354 9173 1999 127-128
18. Herings R.M. Klungel O.H. An epidemiological approach to assess the economic burden of NSAID-induced gastrointestinal events in The Netherlands Pharmacoeconomics 19 6 2001 655-665
19. Zetterstrom O. Buhl R. Mellem H. Andersson F. The whole story: treatment outcomes with symbicort Respir Med 96 Suppl A 2002 S29-S35
20. van Schayck C.P. Postma D.S. Lammers J-.W. The place of long-acting beta 2 adrenergic agonists in the treatment of asthma and chronic obstructive lung disease (COPD) Ned Tijdschr Geneeskd 143 3 1999 137-140
21. Blais L. Ernst P. Boivin J.F. Suissa S. Inhaled corticosteroids and the prevention of readmission to hospital for asthma Am J Respir Crit Care Med 158 1 1998 126-132
22. Suissa S. Ernst P. Benayoun S. Baltzan M. Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma N Engl J Med 343 5 2000 332-336
23. van Grunsven P.M. Dompeling E. van Schayck C.P. Molema J. Folgering H. van Weel C. Treatment of mild asthma with inhaled corticosteroids: is discontinuation of therapy possible? Fam Med 28 1 1996 46-51
24. Jackevicius C.A. Chapman K.R. Prevalence of inhaled corticosteroid use among patients with chronic obstructive pulmonary disease: a survey Ann Pharmacother 31 2 1997 160-164
25. Jackevicius C. Joyce D.P. Kesten S. Chapman K.R. Prehospitalization inhaled corticosteroid use in patients with COPD or asthma Chest 111 2 1997 296-302
26. van Staa T.P. Cooper C. Leufkens H.G. Lammers J.W. Suissa S. The use of inhaled corticosteroids in the United Kingdom and the Netherlands Respir Med 97 5 2003 578-585
27. van Ganse E. Hubloue I. Vincken W. Leufkens H.G. Gregoire J. Ernst P. Actual use of inhaled corticosteroids and risk of hospitalisation: a case-control study Eur J Clin Pharmacol 51 6 1997 449-454
28. Yuksel N. Ginther S. Man P. Tsuyuki R.T. Underuse of inhaled corticosteroids in adults with asthma Pharmacotherapy 20 4 2000 387-393
29. Dekker F.W. Dieleman F.E. Kaptein A.A. Mulder J.D. Compliance with pulmonary medication in general practice Eur Respir J 6 6 1993 886-890
30. Diette G.B. Wu A.W. Skinner E.A. et-al Treatment patterns among adult patients with asthma: factors associated with overuse of inhaled beta-agonists and underuse of inhaled corticosteroids Arch Intern Med 159 22 1999 2697-2704
31. Markson L.E. Vollmer W.M. Fitterman L. et al. Insight into patient dissatisfaction with asthma treatment Arch Intern Med 161 3 2001 379-384
32. Boulet L.P. Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patients Chest 113 3 1998 587-592
33. Jackson L.D. Polygenis D. McIvor R.A. Worthington I. Comparative efficacy and safety of inhaled corticosteroids in asthma Can J Clin Pharmacol 6 1 1999 26-37
34. Hanania N.A. Chapman K.R. Kesten S. Adverse effects of inhaled corticosteroids Am J Med 98 1995 196-208